ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer
Kimihiro Shimizu(Shinshu University), Izumi Takeyoshi(Gunma University)
Cited by 134
Related Papers
Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer
|BMC Cancer|2013|163
Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma
|Nature Communications|2016|58
Genomic Profiles of Pathogenic and Moderate-Penetrance Germline Variants Associated With Risk of Early-Onset Lung Adenocarcinoma
|Journal of Thoracic Oncology|2025|6